What to do with non-responders to CGRP(r) monoclonal antibodies: switch to another or move to gepants?
Journal of Headache and Pain, cilt.24, sa.1, 2023 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Editöre Mektup
- Cilt numarası: 24 Sayı: 1
- Basım Tarihi: 2023
- Doi Numarası: 10.1186/s10194-023-01698-8
- Dergi Adı: Journal of Headache and Pain
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, MEDLINE, Psycinfo, Directory of Open Access Journals
- Anahtar Kelimeler: CGRP, Combination, Gepants, Responders, Switching
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Gazi Üniversitesi Adresli: Evet
Özet
In this editorial we aim to provide potential therapeutic options in patients who do not benefit from treatment with CGRP(r) monoclonal antibodies. Based on current real-life studies and analysis of practical and economic aspects, we will analyze the potential benefits of changing CGRP-targeted treatment.